Why Now Daily.

Published

H. pylori Tests: Breath, Stool, Blood and Biopsy Compared

H. pylori breath and stool antigen tests detect evidence of active stomach infection and can also confirm eradication after treatment. Endoscopy with biopsy is more invasive but can inspect the stomach and obtain tissue when clinically needed.

Timeline

  1. 2024-09-01: The American College of Gastroenterology published updated H. pylori treatment guidance emphasizing test of cure after therapy.
  2. 2026-10-12: Current government, academic medical-center and gastroenterology-specialty testing guidance was reviewed for this guide.

Helicobacter pylori is a bacterium that can persist in the stomach lining. Many infected people have no symptoms, but the infection can cause chronic gastritis and peptic ulcers and increases long-term stomach-cancer risk. Testing serves two different decisions: whether active infection is present before treatment and whether treatment eradicated it afterward. The best method depends on symptoms, medicines, prior treatment and whether an upper endoscopy is otherwise needed. A test should generally be ordered when a positive result will lead to treatment and follow-up. [1][2][3][4]

A urea breath test detects bacterial urease activity. The patient swallows urea labeled with a special carbon marker; if H. pylori is present, the organism breaks down the urea and labeled carbon dioxide appears in exhaled breath. Samples are compared before and after the dose. The test is noninvasive and can identify current infection or confirm eradication. It requires following the laboratory’s fasting and medicine instructions, and the patient must be able to complete the timed collection steps. [1][2][3][5]

A stool antigen test looks for H. pylori proteins in a stool sample and also detects active infection. Stool PCR can detect bacterial genetic material and, where available, may report resistance-related changes, though access and cost vary. Collection instructions matter: keep the specimen separate from urine, toilet water and paper, label it and return it as directed. Breath and stool antigen tests are both useful for diagnosis and test of cure, so practical availability and patient circumstances often guide the choice. [1][3]

An antibody blood test answers a different question. It can show that the immune system has encountered H. pylori, but antibodies may remain detectable for years after the bacteria are gone. A positive antibody result therefore cannot reliably distinguish current from past infection and cannot prove cure. Blood serology is consequently used less often when breath or stool testing is available. Readers should check the exact test name rather than assuming that every result labeled “H. pylori positive” carries the same meaning. [1][5]

Upper endoscopy lets a clinician inspect the esophagus, stomach and duodenum and collect stomach biopsies for urease testing, histology, culture or other analysis. It is more invasive than breath or stool testing and requires preparation, sedation planning and a small procedural risk, so it is not usually chosen solely to screen for H. pylori. It becomes useful when alarm symptoms, bleeding, persistent symptoms or another clinical question warrants direct inspection, or when tissue may help investigate treatment failure and antibiotic susceptibility. [1][3]

Medication timing can turn an active-infection test falsely negative. The 2024 American College of Gastroenterology highlights advise waiting at least four weeks after antibiotics and bismuth before a test of cure and withholding proton-pump inhibitors or potassium-competitive acid blockers for two weeks. The ordering team may use other acid relief during that interval when appropriate. Requirements can vary with the assay and individual, so disclose every prescription, over-the-counter medicine and recent antibiotic and follow the clinician’s exact hold instructions rather than stopping treatment independently. [1][3][6][7]

Symptoms improving does not prove that H. pylori is gone, and persistent discomfort does not prove treatment failed. Current ACG guidance calls for proof of eradication in all treated patients using a urea breath test, fecal antigen test or biopsy-based test at least four weeks after therapy, with the required medicine holds. Serology is unsuitable for that task. If the test remains positive, the clinician reviews adherence, previous antibiotics and local or measured resistance before choosing another regimen, then confirms eradication again. [3][6][7][8]

Ask whether the ordered method detects active infection, how to prepare, when it should occur relative to medicines and treatment, and how a result will change care. Do not take leftover antibiotics before sampling or assemble an eradication regimen without a clinician; incomplete or poorly chosen therapy can fail and promote resistance. Seek urgent medical care for black tarry stool, vomiting blood or coffee-ground material, fainting, a rapid pulse, or sudden severe abdominal pain. Those signs can indicate ulcer bleeding or perforation and should not wait for routine H. pylori testing. [1][6][8]

Sources

  1. MedlinePlus — Helicobacter pylori Tests
  2. NIDDK — Diagnosis of Gastritis and Gastropathy
  3. Mayo Clinic — H. pylori Infection: Diagnosis and Treatment
  4. MedlinePlus — Helicobacter pylori Infections
  5. MedlinePlus Medical Encyclopedia — Tests for H. pylori
  6. American College of Gastroenterology — H. pylori Guideline Highlights 2024
  7. American College of Gastroenterology — New Recommendations for H. pylori Treatment
  8. NIDDK — Treatment of Gastritis and Gastropathy

Related stories